CANTATA EvaluatorSM for CVM

Methodology  

New CE:  
Company Information
Symbol: CVM
Company: CEL-SCI CORP
Company Description:
Stock is Optionable: No
SEC Filings Edgar Online
General Due Diligence and Earnings Date Info: Due Diligence
Exchange: 0
CANTATA Evaluation for 11/21/2024
CE Zone
Time- liness CET CEF CE* Industry Industry
Rank
Industry
Score
1-2 0/2 0.1 / 7 4.4 / 11 4.5 /18 Biotechnology 80 / 215 71 / 100
*Excluding Timeliness points
Timeliness
Item Data Points Maximum
Possible
1
Currently listed on CwH, DB, HTF or SQZ watchlists
0 1
2
Broke out in last 5 days and within 5% of BoP
0 1
 
Total Timeliness Points
0 2
CANTATA Evaluation Technical (CET)
Item Data Points Maximum
Possible
1 Price relative to 50 and 200 day moving averages; 50 day relative to 200 day moving average
Last Close: $ 0.628
50 dma $ 0.94
200 dma $ 1.41
0.00 3
2 Relative Strength Rank
RS 3
0.06 3
3 Rank in Industry
Rank in Industry 601
# of stocks in Industry 601
0.04 1
4 Price relative to 52 week high
% off 52 week high 80.56 %
0.00 1
5 Up/Down Ratio
Up/Down Ratio: 0.6
0.00 1
  Miscellaneous Technical Data (no points assigned)
Beta 0.660
PE (vs. S&P 500) -9999999999.990 (-496770988.57 x)
5yr PE low - high -9999999999.990 - 0
n/a n/a
  Total Technical Points (CET) 0.10 9
CANTATA Evaluation Fundamentals (CEF)
1 Quarter over Quarter Earnings Growth
06/30/24 -0.139 vs. -0.189 [ 26.46 %]
03/31/24 -0.139 vs. -0.191 [ 27.23 %]
12/31/23 -0.138 vs. -0.185 [ 25.41 %]
09/30/23 -0.164 vs. -0.210 [ 21.90 %]
1.00 1
2 Positive Quarterly Earnings 0.60 1
3 Quarterly Earnings Growth Acceleration 0.80 1
4 Year over Year Earnings Growth Rates
09/30/23 [ 0 %]    
09/30/22 [ 0 %]    
09/30/21 [ 0 %]    
09/30/20 [ 0 %]    
09/30/19 [ 0 %]    
0.00 1
5 Quarter over Quarter Sales Growth Rates
06/30/24 -9999999999.990 vs. -9999999999.990 [ 0 %]
03/31/24 -9999999999.990 vs. -9999999999.990 [ 0 %]
12/31/23 -9999999999.990 vs. -9999999999.990 [ 0 %]
09/30/23 -9999999999.990 vs. -9999999999.990 [ 0 %]
0.00 1
6 Quarterly Sales Growth Rate Acceleration 0.00 1
7 Forward Earnings Growth Rates
Est. EPS growth current Fiscal Yr to next 27.300 %
Est. EPS Growth Next Fiscal Yr to Following -9999999999.990 %
1.00 1
8 Institutional Ownership
Number of Institutional Owners 76.000
Net shares purchased MRQ ('000)
Institutional Ownership Details  
0.50 1
9 Return on Equity (ROE)
ROE - TTM -239.01 %
0.00 1
10 Cash Flow:
Cash from operations MRQ
Earnings TTM 0
Cash from operations TTM
Cash flow above/below earnings TTM 0
0.50 1
11 Net Margins
09/30/23 -9999999999.990%
09/30/22 -9999999999.990%
09/30/21 -9999999999.990%
0.00 1
  Miscelleneous Fundamental Data (no points assigned)
Financial Overview
Long term debt to equity 117.600 %  
Current Fiscal Year End 09/30/24  
Yearly Sales ('000) 09/30/23 -9999999999.990
      09/30/22 -9999999999.990
      09/30/21 -9999999999.990
      09/30/20 0.600
      09/30/19 0.500
n/a n/a
  Total Fundamental Points (CEF) 4.40 11
  Total CANTATA Evaluation Points 4.50 20